Based on Bae et al.’s study [20], the inhibitory effects of apamin have been demonstrated through c-Jun N-terminal kinases (JNK) inactivation in a cerulein-induced AP model in vivo. The gene discussed is MAPK8; the disease is alkaline phosphatase measurement.